Ensuring Compliance With Tamper-Evident Pharmaceutical Packaging

A tamper-evident solution is essential to comply with EU Directive 2011/62/EU. Pharmaceutical manufacturers and packaging companies need to decide now how they will meet these regulations. The EU does however allow leeway for implementation approaches that are optimally adapted to individual's financial and technical circumstances. Tamper verification features ensure that any illicit opening of the outer packaging during the supply chain, for example to replace a product's contents, is immediately apparent. 

This white paper explains the implications of the EU directive 2011/62/EU and EN 16679 and how this will affect pharmaceutical packaging. It specifically deals with the devices which can be applied to check if packaging has been tampered with.